Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In Vitro Inhibition of Renal OCT2 and MATE1 Secretion by Antiemetic Drugs. | Int J Mol Sci | 2021 | 34208557 | PubTator, text mining | PubMed |
| Polyamines: Functions, Metabolism, and Role in Human Disease Management. | Med Sci (Basel) | 2021 | 34207607 | PubTator, text mining | PubMed |
| Urine-Derived Epithelial Cells as Models for Genetic Kidney Diseases. | Cells | 2021 | 34204173 | PubTator, text mining | PubMed |
| The Mechanism of Drug Nephrotoxicity and the Methods for Preventing Kidney Damage. | Int J Mol Sci | 2021 | 34204029 | PubTator, text mining | PubMed |
| Targeting the Copper Transport System to Improve Treatment Efficacies of Platinum-Containing Drugs in Cancer Chemotherapy. | Pharmaceuticals (Basel) | 2021 | 34201235 | PubTator, text mining | PubMed |
| Meta-Assessment of Metformin Absorption and Disposition Pharmacokinetics in Nine Species. | Pharmaceuticals (Basel) | 2021 | 34200427 | PubTator, text mining | PubMed |
| A Two-Stage Study Identifies Two Novel Polymorphisms in PRKAG2 Affecting Metformin Response in Chinese Type 2 Diabetes Patients. | Pharmgenomics Pers Med | 2021 | 34188521 | PubTator, text mining | PubMed |
| Integrated network analysis identifying potential novel drug candidates and targets for Parkinson's disease. | Sci Rep | 2021 | 34162989 | PubTator, text mining | PubMed |
| Computational Investigation Identified Potential Chemical Scaffolds for Heparanase as Anticancer Therapeutics. | Int J Mol Sci | 2021 | 34156395 | PubTator, text mining | PubMed |
| OCT1 Polyspecificity-Friend or Foe? | Front Pharmacol | 2021 | 34149437 | PubTator, text mining | PubMed |
| Pharmacokinetics of gallic acid and protocatechuic acid in humans after dosing with Relinqing (RLQ) and the potential for RLQ-perpetrated drug-drug interactions on organic anion transporter (OAT) 1/3. | Pharm Biol | 2021 | 34144662 | PubTator, text mining | PubMed |
| Computational study to discover potent phytochemical inhibitors against drug target, squalene synthase from Leishmania donovani. | Heliyon | 2021 | 34141935 | PubTator, text mining | PubMed |
| Expression and Function of Organic Cation Transporter 2 in Pancreas. | Front Cell Dev Biol | 2021 | 34124075 | PubTator, text mining | PubMed |
| Bioinformatics, Molecular Docking and Experiments In Vitro Analyze the Prognostic Value of CXC Chemokines in Breast Cancer. | Front Oncol | 2021 | 34123826 | PubTator, text mining | PubMed |
| Napabucasin Drug-Drug Interaction Potential, Safety, Tolerability, and Pharmacokinetics Following Oral Dosing in Healthy Adult Volunteers. | Clin Pharmacol Drug Dev | 2021 | 34107166 | PubTator, text mining | PubMed |
| Screening of natural compounds from Cyperus rotundus Linn against SARS-CoV-2 main protease (Mpro): An integrated computational approach. | Comput Biol Med | 2021 | 34090015 | PubTator, text mining | PubMed |
| Incorporation of Sulfonamide Moiety into Biguanide Scaffold Results in Apoptosis Induction and Cell Cycle Arrest in MCF-7 Breast Cancer Cells. | Int J Mol Sci | 2021 | 34073245 | PubTator, text mining | PubMed |
| Genetics of Body Fat Distribution: Comparative Analyses in Populations with European, Asian and African Ancestries. | Genes (Basel) | 2021 | 34072523 | PubTator, text mining | PubMed |
| Synthesis and Characterization of Some New Quinoxalin-2(1H)one and 2-Methyl-3H-quinazolin-4-one Derivatives Targeting the Onset and Progression of CRC with SAR, Molecular Docking, and ADMET Analyses. | Molecules | 2021 | 34071141 | PubTator, text mining | PubMed |
| A Review of Mathematics Determining Solute Uptake at the Blood-Brain Barrier in Normal and Pathological Conditions. | Pharmaceutics | 2021 | 34069733 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=39